REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,118.00
Bid: 12,120.00
Ask: 12,124.00
Change: 68.00 (0.56%)
Spread: 4.00 (0.033%)
Open: 11,966.00
High: 12,162.00
Low: 11,966.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-UK blue chips hit 9-month high on Brexit trade deal cheer

Tue, 29th Dec 2020 09:52

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* Brexit deal sparks rally in UK stocks

* FTSE 100 at highest since March

* Hut Group rises on online retailer acquisition

* FTSE 100 up 1.6%, FTSE 250 adds 1.7%
(Updates to market close)

By Shivani Kumaresan

Dec 29 (Reuters) - Britain's blue-chip FTSE 100 index ended
at its highest since March on Tuesday as investors returned from
a long weekend to cheer a post-Brexit trade deal that averted a
chaotic exit from the European Union.

In its first day of trading after the deal, the blue-chip
FTSE 100 index gained 1.6%, logging its best day since
Nov. 9.

International companies such as Unilever and Diageo
gave the biggest boost to the FTSE 100 despite a firmer
pound, while drugmakers AstraZeneca and GlaxoSmithKline
also added to the gains.

"The deal should see sentiment towards the FTSE indices
recover just as the dividend payout ratio improves, vaccines are
rolled out and overseas revenues accelerate. We lift UK equities
to Bullish," analysts at brokerage Jefferies wrote in a note.

The coming days will provide a first taste of the effects of
Brexit and regulators on both sides of the English Channel will
be on alert for market dislocations on Jan. 4, the first trading
day of the new year.

"The honest answer is we do not know what January 1st will
hold. In all likelihood, there will be delays and bedding-in
period as the new reality and processes are explored and
enacted," said Jeffrey Halley, senior market analyst at OANDA.

The deal would ensure traded goods that make up half of
annual EU-UK commerce remain free of tariffs beyond Dec. 31.

The domestically-focussed FTSE 250 index climbed
1.7% to its highest level since Feb. 25.

The UK stock market has tracked a global rally this year
following the coronavirus-led crash in March, but lagged
European and U.S. peers on fears of a long road to pre-pandemic
levels of economic growth.

On individual stocks, shares in Hut Group rose 8.9%
after the e-commerce company said it would buy U.S. online
retailer Dermstore from Target Corp for $350 million in
cash.

British insurer Admiral gained 3.4% after reports
of Zoopla Property Group buying its Penguin Portals and Preminen
businesses.
(Reporting by Shivani Kumaresan in Bengaluru; Editing by
Subhranshu Sahu, Aditya Soni and Emelia Sithole-Matarise)

More News
14 Mar 2024 10:01

TOP NEWS: AstraZeneca buys France's Amolyt Pharma for USD1 billion

(Alliance News) - AstraZeneca PLC on Thursday said it has struck a deal to acquire Amolyt Pharma SAS, strengthening its late-stage rare disease pipeline.

Read more
14 Mar 2024 07:52

LONDON BRIEFING: Astra makes USD1.05 billion buy; Halma backs outlook

(Alliance News) - London's FTSE 100 is set to tread water after the opening bell sounds on Thursday, as investors look to a batch of US data to come in the early afternoon.

Read more
14 Mar 2024 07:16

AstraZeneca snaps up rare disease specialist Amolyt for $1.05bn

(Sharecast News) - Biopharma giant AstraZeneca has announced the acquisition of French biotech firm Amolyt Pharma for up to $1.05bn to beef up its late-stage rare disease pipeline.

Read more
8 Mar 2024 06:00

Astra, Sanofi's antibody 90% effective against RSV in infants - CDC

(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.

Read more
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.